Tuesday, July 7, 2026 | TSX: 24,847 ▲ 0.44% | Gold: $3,342 ▼ 0.19% | BTC: $108,240 ▲ 1.82%
NewsletterAdvertiseAbout
Subscribe Free
Live
TSX24,847▲ +0.44%
S&P 5005,612▲ +0.31%
Gold$3,342▼ −0.19%
BTC$108,240▲ 1.82%
WTI$78.40▲ +1.12%
USD/CAD1.3612▼ −0.08%
Silver$33.80▲ +0.62%
Uranium$92.50▲ +2.44%
TSX24,847▲ +0.44%
S&P 5005,612▲ +0.31%
Gold$3,342▼ −0.19%
BTC$108,240▲ 1.82%
WTI$78.40▲ +1.12%
USD/CAD1.3612▼ −0.08%
Silver$33.80▲ +0.62%
Uranium$92.50▲ +2.44%
CSE Biotech

CSE Biotech

🔶
Biotech
Three CSE-Listed Biotechs With Active Phase 2 Trials That Analysts Are Watching
Author · July 1, 2026
🪙
Biotech
Butterfly Network’s Handheld Ultrasound Is Reshaping Point-of-Care Diagnostics
Author · June 30, 2026
📊
Biotech
GenScript and CRISPR: How Gene Editing Is Moving From Lab to Clinic at Record Speed
Author · June 28, 2026

The Boreal Brief

Canadian markets intelligence delivered every morning before the open. Free.